FDA Adverse Event Malfunction Summary report: N

TRANSEND GUIDEWIRE

MDR report key: 1678105 · Received May 10, 2010

Report

Report Number
2939204-2010-00664
Event Type
Malfunction
Date Received
May 10, 2010
Date of Event
March 2, 2010
Report Date
April 15, 2010
Manufacturer
BOSTON SCIENTIFIC - MIAMI
Product Code
DQX
PMA / PMN Number
UNKNOWN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CN
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PMA# OR 510K#: K934122; K931584; K944677; K971254; K022357 AND K931584.PENDING FULL ANALYSIS OF THE RETURNED DEVICE.

Additional Manufacturer Narrative · 1

VISUAL INSPECTION OF THE RETURNED GUIDEWIRE NOTED THE DEVICE WAS KINKED AND THE POLYTETRAFLUOROETHYLENE (PTEF) COATING WAS PEELED AT 55.3, 56 AND 56.9CM FROM ITS PROXIMAL END. AN ADHESION TEST CONFIRMED THERE WAS PROPER ADHESION OF THE COATING. BASED ON THE INFORMATION PROVIDED AND THE INVESTIGATION RESULTS, THE TORTUOUS ANATOMY MAY HAVE CAUSED A HIGH FRICTION ENCOUNTERED DURING THE PROCEDURE. SUBSEQUENTLY, THE PHYSICIAN MAY HAVE APPLIED EXCESSIVE FORCE TO OVERCOME RESISTANCE, WHICH COULD HAVE CAUSED THE DAMAGE TO THE PTFE COATING OF THE GUIDEWIRE. AS TORTUOUS ANATOMY AND FRICTION ARE CONSIDERED TO BE PROCEDURAL FACTORS, THEREFORE; A ROOT CAUSE OF OPERATIONAL CONTEXT HAS BEEN ASSIGNED TO THE EVENT.

Description of Event or Problem · 1

INITIAL VISUAL INSPECTION OF THE RETURNED DEVICE NOTED THAT THE POLYTETRAFLUOROETHYLENE (PTFE) COATING ON THE GUIDEWIRE HAD BEEN PEELED OFF ON SEVERAL PLACES ALONG ITS LENGTH. THERE WAS NO CLINICAL CONSEQUENCE TO THE PATIENT.

Description of Event or Problem · 1

INITIAL VISUAL INSPECTION OF THE RETURNED DEVICE NOTED THAT THE POLYTETRAFLUOROETHYLENE (PTFE) COATING ON THE GUIDEWIRE HAD BEEN PEELED OFF ON SEVERAL PLACES ALONG ITS LENGTH. THERE WAS NO CLINICAL CONSEQUENCE TO THE PATIENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TRANSEND GUIDEWIRE WIRE, GUIDE, CATHETER DQX BOSTON SCIENTIFIC - MIAMI UNK532

Patients

Seq Age Sex Outcome Treatment
1 57 YR TRANSEND GUIDEWIRE (BOSTON SCIENTIFIC)| NEUROFORM STENT SYSTEM (BOSTON SCIENTIFIC)